# TO FULLY FUND PERFORMANCE UNDER TASK ORDER NO. 9. PERIOD OF PERFORMANCE: 07/02/2020 - 09/02/2020. N01DA-15-8919.

> **NIH NIH N01** · XENOTECH, LLC · 2020 · $23,973

## Abstract

The scope of this task is to perform in vitro metabolism studies of test compounds by hepatic microsomes or hepatocytes from a variety of species for metabolic stability and estimate intrinsic clearance; archival maintenance; and administrative support.
a) The Contractor shall perform in vitro metabolism studies on three (3) compounds (to be identified) as described in Task #6 (Metabolic Stability) of the contract.
b) The Contactor shall provide study reports for each individual compound tested as described in the contract and as directed by the COR.

## Key facts

- **NIH application ID:** 10285772
- **Project number:** 271201500018C-P00013-9999-3
- **Recipient organization:** XENOTECH, LLC
- **Principal Investigator:** MARK WATKINS
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $23,973
- **Award type:** —
- **Project period:** 2015-07-06 → 2020-07-05

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10285772

## Citation

> US National Institutes of Health, RePORTER application 10285772, TO FULLY FUND PERFORMANCE UNDER TASK ORDER NO. 9. PERIOD OF PERFORMANCE: 07/02/2020 - 09/02/2020. N01DA-15-8919. (271201500018C-P00013-9999-3). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10285772. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*